drugset

drugset / Trial / NCT00405496

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

NCT00405496 ↗

Phase 2 Completed 24 enrolled Sirion Therapeutics, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of uveitis.

Timeline

Start: 2000-03
Primary completion: —
Completion: 2001-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Difluprednate	Small molecule	0.05 %	—

Indications